| Financial Year |
March 31 2023 |
| Monetary Funds |
1,474,028,188.69 |
| Held-for-trading Financial Assets |
187,607.65 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,628,660,818.38 |
| Advances to Suppliers |
146,082,988.28 |
| Other Receivables |
11,202,096.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,642,894,394.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
182,651,221.43 |
| Total Current Assets |
5,302,540,455.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,883,353,923.22 |
| Under-construction Projects |
2,915,845,415.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
947,319,474.30 |
| R&D expenses |
77,443,171.86 |
| Goodwill |
22,515,758.61 |
| Long-Term Deferred and Prepaid Expenses |
3,073,882.80 |
| Deferred Income Tax Assets |
59,369,639.12 |
| Other Non-Current Assets |
439,476,105.92 |
| Sub-Total of Non-Current Assets |
8,361,258,460.98 |
| Total Assets |
13,663,798,916.24 |
| Short-Term Loans |
295,209,305.55 |
| Trading Financial liabilities |
200,709.60 |
| Notes Payable |
1,179,160,168.32 |
| Accounts Payable |
980,969,706.32 |
| Accounts Received In Advance |
1,525,896.10 |
| Employee Compensation Payable |
189,335,034.70 |
| Taxes Payable |
144,262,307.51 |
| Interest Payable |
-- |
| Dividend Payable |
400,218,614.00 |
| Other payables |
544,598,964.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
323,993,020.59 |
| Other Current Liabilities |
20,768,910.04 |
| Sub-Total of Current Liabilities |
3,904,652,764.88 |
| Long-term Loans |
1,151,649,323.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
39,979,187.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,578,071.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,456,245,024.70 |
| Total Liabilities |
5,360,897,789.58 |
| Paid-In Capital(Or Share Stock) |
800,437,228.00 |
| Capital Surplus |
1,511,232,763.12 |
| Surplus Reserve |
345,591,784.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,477,280,994.63 |
| Minority Stockholder's Interest |
1,154,038,458.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,148,862,668.32 |
| Owner's Equity（Stockholder's Equity） |
8,302,901,126.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,663,798,916.24 |
